EX-99.1 2 ea023625901ex99-1_ellomay.htm PRESS RELEASE: "ELLOMAY CAPITAL REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR OF 2024," DATED MARCH 31, 2025

Exhibit 99.1

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2024

Tel-Aviv, Israel, Mar. 31, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today reported its unaudited consolidated financial results for the fourth quarter and year ended December 31, 2024.

Financial Highlights

●

Total assets as of December 31, 2024 amounted to approximately €676.7 million, compared to total assets as of December 31, 2023 of approximately €612.9 million.

●

Revenues¹ for the three months ended December 31, 2024 were approximately €8.7 million, compared to revenues of approximately €8.4 million for the three months ended December 31, 2023. Revenues for the year ended December 31, 2024 were approximately €40.5 million, compared to revenues of approximately €48.8 million for the year ended December 31, 2023.

●

Loss from continuing operations for the three months ended December 31, 2024 was approximately €12 million, compared to loss from continuing operations of approximately €8 million for the three months ended December 31, 2023. Loss from continuing operations for the year ended December 31, 2024 was approximately €9.6 million, compared to profit from continuing operations of approximately €2.4 million for the year ended December 31, 2023.

Loss for the three months ended December 31, 2024 was approximately €12 million, compared to loss of approximately €9.8 million for the three months ended December 31, 2023. Loss for the year ended December 31, 2024 was approximately €9.5 million, compared to profit of approximately €0.6 million for the year ended December 31, 2023.

●

EBITDA for the three months ended December 31, 2024 was approximately €7.6 million, compared to EBITDA loss of approximately €2.5 million for the three months ended December 31, 2023. EBITDA for the year ended December 31, 2024 was approximately €25.1 million, compared to EBITDA of approximately €18.8 million for the year ended December 31, 2023. See below under “Use of Non-IFRS Financial Measures” for additional disclosure concerning EBITDA.

●

On December 31, 2023, the Company executed an agreement to sell its holdings in the 9 MW solar plant located in Talmei Yosef. The sale was consummated on June 3, 2024, and the net consideration received at closing was approximately NIS 42.6 million (approximately €10.6 million). In connection with the sale, the Company presents the results of this solar plant as a discontinued operation.

Financial Overview for the Year Ended December 31, 2024

●

Revenues¹ were approximately €40.5 million for the year ended December 31, 2024, compared to approximately €48.8 million for the year ended December 31, 2023. This decrease mainly results from a reduction in electricity prices in Spain between February and May 2024 and lower gas prices in the Netherlands in 2024 compared to prices in 2023, partially offset by income generated by our 20 MW solar power plants in Italy which were connected to the grid during 2024. The decrease is also due to loss of revenues in connection with the fire near the Talasol Solar S.L. (300 MV solar) (“Talasol”) and Ellomay Solar S.L. (28 MV solar) (“Ellomay Solar”) facilities in Spain in July 2024. In connection with such loss of revenues, the Company recorded an amount of approximately €1.7 million as ‘other income’ for the year ended December 31, 2024, based on compensation from the insurers for loss of income.

●

Operating expenses were approximately €19.8 million for the year ended December 31, 2024, compared to approximately €22.9 million for the year ended December 31, 2023. This decrease mainly results from a decrease in direct taxes on electricity production paid by the Company’s Spanish subsidiaries as a result of reduced electricity prices. The operating expenses of the Company’s Spanish subsidiaries for the year ended December 31, 2023 were impacted by the Spanish RDL 17/2022, which established the reduction of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases, accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. The increased expenses during the year ended December 31, 2023 resulting from this impact, were partially offset by lower costs in connection with the acquisition of feedstock by our Dutch biogas plants. Depreciation and amortization expenses were approximately €16.5 million for the year ended December 31, 2024, compared to approximately €16 million for the year ended December 31, 2023.

The revenues presented in the Company’s financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company’s investor presentation.

●

Project development costs were approximately €4.1 million for the year ended December 31, 2024, compared to approximately €4.5 million for the year ended December 31, 2023.

●

General and administrative expenses were approximately €6.1 million for the year ended December 31, 2024, compared to approximately €5.3 million for the year ended December 31, 2023. The increase in general and administrative expenses is mostly due to higher consultancy expenses.

●

Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €11.1 million for the year ended December 31, 2024, compared to approximately €4.3 million for the year ended December 31, 2023. The increase in share of profits of equity accounted investee resulted mainly from the increase in revenues of Dorad Energy Ltd. (“Dorad”) due to higher quantities of electricity produced partially offset by an increase in operating expenses in connection with the increased production. In addition, in December 2024, Dorad received payment in an amount of approximately $130 million pursuant to an arbitration ruling in a derivative claim submitted by certain of its shareholders, which increased Dorad’s net profit for 2024 by approximately NIS 215.6 million (after the effect of taxes). These amounts were recorded by Dorad in its financial statements for the year ended December 31, 2024 in the income statement partially as a reduction in depreciation expenses, partly as finance income, and the remainder as a decrease in general and administrative expenses.

●

Other income, net was approximately €3.4 million for the year ended December 31, 2024, compared to €0 for the year ended December 31, 2023. The income was recognized based on insurance compensation in connection with the fire near the Talasol and Ellomay Solar facilities in Spain in July 2024, net of impairment expenses related to the damaged fixed assets. The amount to be received due to loss of income is approximately €1.7 million.

●

Financing expense, net was approximately €19.7 million for the year ended December 31, 2024, compared to financing expense, net of approximately €3.6 million for the year ended December 31, 2023. The increase in financing expenses, net, was mainly attributable to higher expenses resulting from exchange rate differences that amounted to approximately €7.8 million for the year ended December 31, 2024, compared to income from exchange rate differences of approximately €6.7 million for the year ended December 31, 2023, an aggregate change of approximately €14.5 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures and were caused by the 5.4% reevaluation of the NIS against the euro during the year ended December 31, 2024, compared to a devaluation of 6.9% during the year ended December 31, 2023. The increase in financing expenses for the year ended December 31, 2024 was also due to increased interest expenses mainly resulting from the issuance of the Company’s Series F Debentures in January, April, August and November 2024. These increases in financing expenses were partially offset by an increase in financing income of approximately €0.9 million in connection with derivatives and warrants in the year ended December 31, 2024, compared to the year ended December 31, 2023.

●

Tax benefit was approximately €1.5 million for the year ended December 31, 2024, compared to a tax benefit of approximately €1.4 million for the year ended December 31, 2023.

●

Loss from continuing operations for the year ended December 31, 2024 was approximately €9.6 million, compared to profit from continuing operations of approximately €2.4 million for the year ended December 31, 2023.

●

Profit from discontinued operation (net of tax) for the year ended December 31, 2024 was approximately €137 thousand, compared to loss from discontinued operation of approximately €1.8 million for the year ended December 31, 2023.

●

Loss for the year ended December 31, 2024 was approximately €9.5 million, compared to a profit of approximately €0.6 million for year ended December 31, 2023.

●

Total other comprehensive income was approximately €13.1 million for the year ended December 31, 2024, compared to total other comprehensive income of approximately €41.3 million for the year ended December 31, 2023. The change in total other comprehensive income mainly results from foreign currency translation adjustments due to the change in the NIS/euro exchange rate and from changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the “Talasol PPA”). The Talasol PPA experienced high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows.

●

Total comprehensive income was approximately €3.6 million for the year ended December 31, 2024, compared to total comprehensive income of approximately €41.9 million for the year ended December 31, 2023.

●

Net cash provided by operating activities was approximately €8 million for the year ended December 31, 2024, compared to approximately €8.6 million for the year ended December 31, 2023. The decrease in net cash provided by operating activities for the year ended December 31, 2024, is mainly due to the decrease in electricity prices in Spain. In addition, during the year ended December 31, 2023, the Company’s Dutch biogas plants elected to temporarily exit the subsidy regime and sell the gas at market prices and during the year ended December 31, 2024 these plants returned to the subsidy regime. Under the subsidy regime, plants are entitled to monthly advances on subsidies based on the production during the previous year. As no subsidies were paid to the Company’s Dutch biogas plants for 2023, these plants were entitled to low advance payments for 2024 and the payment for gas produced by the plants during 2024 is expected to be received until July 2025 and reflected accordingly in the Company’s cash flow from operations.

CEO Review for 2024

In 2024, the Company presented an increase of 71% in the operating profit to approximately €7.7 million and of 33.5% in the EBITDA to approximately €25.1 million compared to 2023, despite a decrease of approximately €9 million in the annual revenues, which was caused by low and even negative electricity prices in Spain in the first half of 2024. During 2024 and in recent months the Company made significant advancements in the development of new projects, which are expected to contribute to an increase in revenues in coming years:

In Italy – finance agreements were executed with respect to projects with an aggregate capacity of 198 MW (of which 38 MW are already connected to the electricity grid) and construction agreements for the remainder of the projects with an aggregate capacity of 160 MW were also executed.

In the USA – the Company is advancing additional projects with an aggregate capacity of approximately 50 MW that are expected to begin construction during 2025.

In the Netherlands – the Company advanced in obtaining licenses to expand the operations of the biogas facilities by additional 50% while making relatively small investments.

In Israel – the approval of the National Infrastructures Committee to expand the Dorad power plant by 650 MW was received.

Operating expenses in 2024 decreased by approximately €3 million compared to 2023. Project development expenses in 2024 decreased by approximately €0.4 million compared to 2023 despite the inclusion of non-recurring expenses of approximately €0.5 million in connection with the cancellation of a guarantee in the project development expenses for 2024. Following the advancement of project development and the transition to the construction stage, the decrease in project development expenses is expected to continue during the year.

The appreciation of the NIS against the euro at the end of 2024 caused revaluation losses of approximately €7.8 million compared to revaluation profit of approximately €6.7 million in 2023. The aggregate change is approximately €14.5 million and is the main cause for the increase in financing expenses in 2024.

In March 2025 a transaction was executed between Zorlu Enerji Elektrik Üretim A.S (“Zorlu”) and The Phoenix Insurance Company Ltd. for the sale of Zorlu’s entire holdings in Dorad (25% of Dorad’s outstanding shares). The consideration for the shares represents a value of NIS 2.8 billion for Dorad. Ellomay Luzon Energy Infrastructures Ltd. (50% held by the Company), which currently holds 18.75% of Dorad’s shares, has a right of first refusal over 15% of Dorad’s shares included in the transaction. The Company believes that the price is attractive and therefore intends to act to exercise the right of first refusal. Activity in Spain:

The electricity prices in the second half of 2024 increased and stabilized on the projected seasonal price. The revenues from the sale of electricity in 2024 were approximately €23 million compared to approximately €32 million in 2023. The decrease is primarily attributable to the low/negative electricity prices in the first half of 2024, as well as to the loss of revenues in the amount of approximately €1.7 million due to a fire. The loss of revenues due to the fire will be covered in full by the insurance company.

Activity of Dorad:

In 2024, the Dorad power plant recorded an increase in profit, with net profit of approximately NIS 452.3 million, an increase of approximately NIS 241 million compared to 2023. The Dorad power station received the approval of the National Infrastructures Committee and a positive connection survey to increase the capacity by an additional 650 MW. Due to the final award in the arbitration against Edeltech and Zorlu, Dorad received during 2024 compensation of approximately $130 million that increased Dorad’s net profit for 2024 by approximately NIS 215.6 million (after the effect of taxes).

Activity in the USA:

In the USA, the development and construction activities of solar projects are progressing at a rapid pace and the construction of the first four projects, with a total capacity of approximately 49 MW, began in early 2024. At the end of 2024, construction of two projects (in an aggregate capacity of approximately 27 MW) was completed and the IRS approval of entitlement to tax credits was received. These projects were connected to the electricity grid at the end of March 2025. The additional two projects (in an aggregate capacity of approximately 22 MW) are under construction and their construction is expected to end during April and June 2025. Additional projects with an aggregate capacity of approximately 50 MW are under development and are intended to begin construction in 2025. The Company executed an agreement to sell the tax credits of the first four projects for approximately $19 million.

Activity in Italy:

The Company has a portfolio of 460 MW solar projects in Italy of which 38 MW are connected to the grid and operating 294 MW are ready to build and 128 MW are under advanced development. The Company executed construction agreements with the Engineering, Procurement and Construction (“EPC”) contractor for 160 MW that are ready to build, the commencement of construction is expected in the beginning of the second quarter of 2025 and the construction is expected to take approximately 18 months. A financing agreement with a European institutional investor was executed for the financing of the construction of 198 MW (including the connected projects and the projects for which the EPC agreements were executed) for 23 years with a fixed annual interest of 4.5%.

New legislation in Italy prohibits the establishment of new projects on agricultural land. This prohibition increases the value of the Company’s portfolio, which is not subject to the prohibition or located on agricultural land. The Company estimates that new possibilities are emerging for obtaining a power purchase agreement (“PPA”) in Italy, therefore it expects that in the future project financing will be possible more easily and at lower costs.

Activity in Israel:

The Manara Cliff Pumped Storage Project (Company’s share is 83.34%): A project with a capacity of 156 MW, which is in advanced construction stages. The Iron Swords War, which commenced on October 7, 2023, stopped the construction work on the project. The project has protection from the state for damages and losses due to the war within the framework of the tariff regulation (covenants that support financing). The project was expected to reach commercial operation during the first half of 2027 and the continuation of the Iron Swords war will cause a delay in the date of activation. The Israeli Electricity Authority currently approved a postponement of sixteen months of the dates for the project. The Company and its partner in the project, Ampa, invested the equity required for the project (other than linkage differences), and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.

Development of Solar licenses combined with storage:

The Komemiyut and Qelahim Projects: each intended for 21 solar MW and 50 MW / hour batteries. The sale of electricity will be conducted through a private supplier.

The Company waived the rights it won in a solar / battery tender process in connection with these projects and therefore paid a forfeiture of guarantee in the amount of NIS 1.8 million and is in advanced negotiations with a local virtual electricity supplier for the execution of a long-term PPA.

The Talmei Yosef Project: intended for 10 solar MW and 22 MW / hour batteries. The request for zoning approval was approved in the fourth quarter of 2023.

The Talmei Yosef Storage Project in Batteries: there is a zoning approval for approximately 400 MW / hour. The project is designed for the regulation of high voltage storage.

Activity in the Netherlands:

During 2024, high production levels were maintained in the Company’s three biogas plants. In addition, significant progress was made in the process of obtaining the licenses to increase production by about 50% in each of the Company’s plants. Increasing production will require relatively small investments and is expected to significantly increase income and EBITDA. Following the directive of the European Union to act to significantly increase the production of green gas, the Dutch parliament approved the legislation mandating the obligation to mix green gas with fossil gas, which will become effective commencing January 1, 2026. This legislation is expected to have a positive effect on revenues from the sale of green gas and the price of the accompanying green certificates. Agreements were executed for the future sale of green certificates for green gas in the context of the new regulation at a price of approximately €1 per certificate. The Company’s Dutch subsidiaries generate approximately 16 million green certificates a year.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 15 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

●

Approximately 335.9 MW of operating solar power plants in Spain (including a 300 MW solar plant in owned by Talasol, which is 51% owned by the Company) and approximately 38 MW of operating solar power plants in Italy;

●

9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel’s total current electricity consumption;

●

Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;

●

83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;

●

Solar projects in Italy with an aggregate capacity of 294 MW that have reached “ready to build” status; and

●

Solar projects in the Dallas Metropolitan area, Texas, USA with an aggregate capacity of approximately 27 MW that are placed in service and in process of connection to the grid and additional 22 MW are under construction.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza, the impact of the continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)

CFO

Tel: +972 (3) 797-1111

Email: hilai@ellomay.com

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Financial Position

	December 31,
	2024			2023			2024
	Unaudited			Audited			Unaudited
	€ in thousands						Convenience Translation into US$ in thousands*
Assets
Current assets:
Cash and cash equivalents		41,134			51,127			42,819
Short term deposits		-			997			-
Restricted cash		656			810			683
Intangible asset from green certificates		178			553			185
Trade and other receivables		20,734			11,717			21,583
Derivatives asset short-term		146			275			152
Assets of disposal groups classified as held for sale		-			28,297			-
		62,848			93,776			65,422
Non-current assets
Investment in equity accounted investee		41,324			31,772			43,017
Advances on account of investments		547			898			569
Fixed assets		482,166			407,982			501,918
Right-of-use asset		34,315			30,967			35,721
Restricted cash and deposits		17,052			17,386			17,751
Deferred tax		9,039			8,677			9,409
Long term receivables		13,411			10,446			13,960
Derivatives		15,974			10,948			16,628
		613,828			519,076			638,973
Total assets		676,676			612,852			704,395

Liabilities and Equity
Current liabilities
Current maturities of long-term bank loans		21,316			9,784			22,189
Current maturities of other long-term loans		5,000			5,000			5,205
Current maturities of debentures		35,706			35,200			37,169
Trade payables		8,856			5,249			9,219
Other payables		10,896			10,859			11,342
Current maturities of derivatives		1,875			4,643			1,952
Current maturities of lease liabilities		714			700			743
Liabilities of disposal groups classified as held for sale		-			17,142			-
Warrants		1,446			84			1,505
		85,809			88,661			89,324
Non-current liabilities
Long-term lease liabilities		25,324			23,680			26,361
Long-term bank loans		245,866			237,781			255,938
Other long-term loans		31,314			29,373			32,597
Debentures		155,823			104,887			162,206
Deferred tax		2,486			2,516			2,588
Other long-term liabilities		939			855			977
Derivatives		288			-			300
		462,040			399,092			480,967
Total liabilities		547,849			487,753			570,291

Equity
Share capital		25,613			25,613			26,662
Share premium		86,271			86,159			89,805
Treasury shares		(1,736	)		(1,736	)		(1,807	)
Transaction reserve with non-controlling Interests		5,697			5,697			5,930
Reserves		14,338			4,299			14,925
Accumulated deficit		(12,019	)		(5,037	)		(12,511	)
Total equity attributed to shareholders of the Company		118,164			114,995			123,004
Non-Controlling Interest		10,663			10,104			11,100
Total equity		128,827			125,099			134,104
Total liabilities and equity		676,676			612,852			704,395

Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US$ 1.041)

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Comprehensive Income

	For the three months ended December 31,						For the year ended December 31,						For the three months ended December 31,			For the year ended December 31,
	2024			2023			2024			2023			2024			2024
	Unaudited						Unaudited			Audited			Unaudited
	€ in thousands (except per share data)												Convenience Translation into US$*
Revenues		8,678			8,424			40,467			48,834			9,033			42,125
Operating expenses		(5,298	)		(5,460	)		(19,803	)		(22,861	)		(5,515	)		(20,614	)
Depreciation and amortization expenses		(4,126	)		(4,265	)		(16,468	)		(16,012	)		(4,295	)		(17,143	)
Gross profit (loss)		(746	)		(1,301	)		4,196			9,961			(777	)		4,368

Project development costs		(790	)		(2,025	)		(4,101	)		(4,465	)		(822	)		(4,269	)
General and administrative expenses		(1,384	)		(1,320	)		(6,063	)		(5,283	)		(1,441	)		(6,311	)
Share of profit (loss) of equity accounted investee		5,767			(279	)		11,062			4,320			6,003			11,515
Other income, net		524			-			3,409			-			545			3,549
Operating profit (loss)		3,371			(4,925	)		8,503			4,533			3,508			8,852

Financing income		710			345			2,495			8,747			739			2,597
Financing income (expenses) in connection with derivatives and warrants, net		(664	)		336			1,140			251			(691	)		1,187
Financing expenses in connection with projects finance		(1,544	)		(1,465	)		(6,190	)		(6,077	)		(1,607	)		(6,444	)
Financing expenses in connection with debentures		(1,762	)		(1,008	)		(6,641	)		(3,876	)		(1,834	)		(6,913	)
Interest expenses on minority shareholder loan		(528	)		(541	)		(2,144	)		(2,014	)		(550	)		(2,232	)
Other financing expenses		(13,099	)		(1,499	)		(8,311	)		(588	)		(13,636	)		(8,651	)
Financing expenses, net		(16,887	)		(3,832	)		(19,651	)		(3,557	)		(17,579	)		(20,456	)

Profit (loss) before taxes on income		(13,516	)		(8,757	)		(11,148	)		976			(14,071	)		(11,604	)
Tax benefit		1,475			799			1,547			1,436			1,535			1,610
Profit (loss) for the period from continuing operations		(12,041	)		(7,958	)		(9,601	)		2,412			(12,536	)		(9,994	)
Profit (loss) from discontinued operation (net of tax)		58			(1,857	)		137			(1,787	)		60			143
Profit (loss) for the period		(11,983	)		(9,815	)		(9,464	)		625			(12,476	)		(9,851	)
Profit (loss) attributable to:
Owners of the Company		(10,887	)		(8,490	)		(6,982	)		2,219			(11,333	)		(7,268	)
Non-controlling interests		(1,096	)		(1,325	)		(2,482	)		(1,594	)		(1,143	)		(2,583	)
Profit (loss) for the period		(11,983	)		(9,815	)		(9,464	)		625			(12,476	)		(9,851	)
Other comprehensive income (loss) item that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss:
Foreign currency translation differences for foreign operations		13,159			1,234			8,007			(7,949	)		13,698			8,335
Foreign currency translation differences for foreign operations that were recognized in profit or loss		-			-			255			-			-			265
Effective portion of change in fair value of cash flow hedges		(3,781	)		(10,718	)		5,631			39,431			(3,937	)		5,861
Net change in fair value of cash flow hedges transferred to profit or loss		1,108			19,183			(813	)		9,794			1,154			(846	)
Total other comprehensive income		10,486			9,699			13,080			41,276			10,915			13,615

Total other comprehensive income (loss) attributable to:
Owners of the Company		11,354			5,172			10,039			16,931			11,818			10,450
Non-controlling interests		(868	)		4,527			3,041			24,345			(903	)		3,165
Total other comprehensive income (loss) for the period		10,486			9,699			13,080			41,276			10,915			13,615
Total comprehensive income (loss) for the period		(1,497	)		(116	)		3,616			41,901			(1,561	)		3,764

Total comprehensive income (loss) attributable to:
Owners of the Company		467			(3,318	)		3,057			19,150			485			3,182
Non-controlling interests		(1,964	)		3,202			559			22,751			(2,046	)		582
Total comprehensive income (loss) for the period		(1,497	)		(116	)		3,616			41,901			(1,561	)		3,764

Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US $ 1.041)

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Comprehensive Income (cont’d)

	For the three months ended December 31,						For the year ended December 31,						For the three months ended December 31,			For the year ended December 31,
	2024			2023			2024			2023			2024			2024
	Unaudited						Unaudited			Audited			Unaudited
	€ in thousands (except per share data)												Convenience Translation into US$*
Basic profit (loss) per share		(0.85	)		(0.66	)		(0.54	)		0.17			(0.91	)		(0.56	)
Diluted profit (loss) per share		(0.85	)		(0.66	)		(0.54	)		0.17			(0.91	)		(0.56	)

Basic profit (loss) per share continuing operations		(0.85	)		(0.14	)		(0.55	)		0.31			(0.91	)		(0.57	)
Diluted profit (loss) per share continuing operations		(0.85	)		(0.14	)		(0.55	)		0.31			(0.91	)		(0.57	)

Basic profit (loss) per share discontinued operation		-			(0.52	)		0.01			(0.14	)		-			0.01
Diluted profit (loss) per share discontinued operation		-			(0.52	)		0.01			(0.14	)		-			0.01

Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US$ 1.041)

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Changes in Equity

					Attributable to shareholders of the Company
	Share capital		Share premium		Accumulated Deficit			Treasury shares			Translation reserve from foreign operations			Hedging Reserve			Interests Transaction reserve with non-controlling Interests		Total			Non- controlling Interests			Total Equity
	€ in thousands
For the year ended December 31, 2024 (unaudited):
Balance as at January 1, 2024		25,613		86,159		(5,037	)		(1,736	)		385			3,914			5,697		114,995			10,104			125,099
Profit (loss) for the period		-		-		(6,982	)		-			-			-			-		(6,982	)		(2,482	)		(9,464	)
Other comprehensive income (loss) for the period		-		-		-			-			8,061			1,978			-		10,039			3,041			13,080
Total comprehensive income (loss) for the period		-		-		(6,982	)		-			8,061			1,978			-		3,057			559			3,616
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		112		-			-			-			-			-		112			-			112
Balance as at December 31, 2024		25,613		86,271		(12,019	)		(1,736	)		8,446			5,892			5,697		118,164			10,663			128,827

For the three months ended December 31, 2024 (unaudited):
Balance as at September 30, 2024		25,613		86,250		(1,132	)		(1,736	)		(4,377	)		7,361			5,697		117,676			12,627			130,303
Profit (loss) for the period		-		-		(10,887	)		-			-			-			-		(10,887	)		(1,096	)		(11,983	)
Other comprehensive income (loss) for the period		-		-		-			-			12,823			(1,469	)		-		11,354			(868	)		10,486
Total comprehensive income (loss) for the period		-		-		(10,887	)		-			12,823			(1,469	)		-		467			(1,964	)		(1,497	)
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		21		-			-			-			-			-		21			-			21
Balance as at December 31, 2024		25,613		86,271		(12,019	)		(1,736	)		8,446			5,892			5,697		118,164			10,663			128,827

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Changes in Equity (cont’d)

					Attributable to shareholders of the Company
	Share capital		Share premium		Accumulated deficit			Treasury shares			Translation reserve from foreign operations			Hedging Reserve			Interests Transaction reserve with non-controlling Interests		Total			Non- controlling Interests			Total Equity
	€ in thousands
For the year ended December 31, 2023 (audited):
Balance as at January 1, 2023		25,613		86,038		(7,256	)		(1,736	)		7,970			(20,602	)		5,697		95,724			(12,647	)		83,077
Profit (loss) for the year		-		-		2,219			-			-			-			-		2,219			(1,594	)		625
Other comprehensive loss for the year		-		-		-			-			(7,585	)		24,516			-		16,931			24,345			41,276
Total comprehensive loss for the year		-		-		2,219			-			(7,585	)		24,516			-		19,150			22,751			41,901
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		121		-			-			-			-			-		121			-			121
Balance as at December 31, 2023		25,613		86,159		(5,037	)		(1,736	)		385			3,914			5,697		114,995			10,104			125,099

For the three months
ended December 31, 2023 (unaudited):
Balance as at September 30, 2023		25,613		86,131		3,453			(1,736	)		(801	)		(72	)		5,697		118,285			6,902			125,187
Profit (loss) for the period		-		-		(8,490	)		-			-			-			-		(8,490	)		(1,325	)		(9,815	)
Other comprehensive income (loss) for the period		-		-		-			-			1,186			3,986			-		5,172			4,527			9,699
Total comprehensive income (loss) for the period		-		-		(8,490	)		-			1,186			3,986			-		(3,318	)		3,202			(116	)
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		28		-			-			-			-			-		28			-			28
Balance as at December 31, 2023		25,613		86,159		(5,037	)		(1,736	)		385			3,914			5,697		114,995			10,104			125,099

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Changes in Equity (cont’d)

					Attributable to shareholders of the Company
	Share capital		Share premium		Accumulated deficit			Treasury shares			Translation reserve from foreign operations			Hedging Reserve			Interests Transaction reserve with non-controlling Interests		Total			Non- controlling Interests			Total Equity
	Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US$ 1.041)
For the year ended December 31, 2024 (unaudited):
Balance as at January 1, 2024		26,662		89,688		(5,243	)		(1,807	)		401			4,074			5,930		119,705			10,518			130,223
Profit (loss) for the period		-		-		(7,268	)		-			-			-			-		(7,268	)		(2,583	)		(9,851	)
Other comprehensive income (loss) for the period		-		-		-			-			8,391			2,059			-		10,450			3,165			13,615
Total comprehensive income (loss) for the period		-		-		(7,268	)		-			8,391			2,059			-		3,182			582			3,764
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		117		-			-			-			-			-		117			-			117
Balance as at December 31, 2024		26,662		89,805		(12,511	)		(1,807	)		8,792			6,133			5,930		123,004			11,100			134,104

For the three months ended December 31, 2024 (unaudited):
Balance as at September 30, 2024		26,662		89,783		(1,178	)		(1,807	)		(4,555	)		7,663			5,930		122,498			13,146			135,644
Profit (loss) for the period		-		-		(11,333	)		-			-			-			-		(11,333	)		(1,143	)		(12,476	)
Other comprehensive income (loss) for the period		-		-		-			-			13,347			(1,530	)		-		11,817			(903	)		10,914
Total comprehensive income (loss) for the period		-		-		(11,333	)		-			13,347			(1,530	)		-		484			(2,046	)		(1,562	)
Transactions with owners of the Company, recognized directly in equity:
Share-based payments		-		22		-			-			-			-			-		22			-			22
Balance as at December 31, 2024		26,662		89,805		(12,511	)		(1,807	)		8,792			6,133			5,930		123,004			11,100			134,104

Ellomay Capital Ltd. and its Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flow

	For the three months ended December 31,						For the year ended December 31,						For the three months ended December 31,			For year ended December 31,
	2024			2023			2024			2023			2024			2024
	Unaudited						Unaudited			Audited			Unaudited
	€ in thousands												Convenience Translation into US$*
Cash flows from operating activities
Profit (loss) for the period		(11,983	)		(9,815	)		(9,464	)		625			(12,476	)		(9,851	)
Adjustments for:
Financing expenses, net		16,887			3,632			19,247			3,034			17,579			20,035
Loss from settlement of derivatives contract		266			-			316			-			277			329
Impairment losses on assets of disposal groups classified as held-for-sale		-			2,565			405			2,565			-			422
Depreciation and amortization		4,126			4,378			16,516			16,473			4,295			17,193
Share-based payment transactions		21			28			112			121			22			117
Share of profits of equity accounted investees		(5,767	)		279			(11,062	)		(4,320	)		(6,003	)		(11,515	)
Payment of interest on loan from an equity accounted investee		-			33			-			1,501			-			-
Change in trade receivables and other receivables		(5,606	)		(1,317	)		(8,824	)		(302	)		(5,836	)		(9,185	)
Change in other assets		2,894			69			3,770			(681	)		3,013			3,924
Change in receivables from concessions project		-			259			793			1,778			-			825
Change in trade payables		48			(332	)		(31	)		(45	)		50			(32	)
Change in other payables		4,747			(2,492	)		4,454			(2,235	)		4,941			4,636
Tax benefit		(1,475	)		(1,391	)		(1,552	)		(1,852	)		(1,535	)		(1,615	)
Income taxes refund (paid)		277			(473	)		623			(912	)		288			649
Interest received		605			524			2,537			2,936			630			2,641
Interest paid		(2,618	)		(4,132	)		(9,873	)		(10,082	)		(2,725	)		(10,277	)
		14,405			1,630			17,431			7,979			14,996			18,147
Net cash provided by (used in) operating activities		2,422			(8,185	)		7,967			8,604			2,520			8,296

Cash flows from investing activities
Acquisition of fixed assets		(22,894	)		(7,365	)		(72,922	)		(58,848	)		(23,832	)		(75,909	)
Interest paid capitalized to fixed assets		(887	)		(2,283	)		(2,515	)		(2,283	)		(923	)		(2,618	)
Proceeds from sale of investments		-			-			9,267			-			-			9,647
Repayment of loan by an equity accounted investee		-			1,221			-			1,324			-			-
Loan to an equity accounted investee		-			(60	)		-			(128	)		-			-
Advances on account of investments		-			-			(163	)		(421	)		-			(170	)
Proceeds from advances on account of investments		514			297			514			2,218			535			535
Proceeds in marketable securities		-			-			-			2,837			-			-
Investment in settlement of derivatives, net		(540	)		-			(316	)		-			(562	)		(329	)
Proceeds from (investment in) restricted cash, net		532			(53	)		689			840			554			717
Proceeds from (investment in) short term deposit		2,408			-			1,004			(1,092	)		2,507			1,045
Net cash used in investing activities		(20,867	)		(8,243	)		(64,442	)		(55,553	)		(21,721	)		(67,082	)

Cash flows from financing activities
Issuance of warrants		-			-			2,666			-			-			2,775
Cost associated with long-term loans		(556	)		(690	)		(2,567	)		(1,877	)		(579	)		(2,672	)
Payment of principal of lease liabilities		(2,276	)		(190	)		(2,941	)		(1,156	)		(2,369	)		(3,061	)
Proceeds from long-term loans		175			10,787			19,482			32,157			182			20,280
Repayment of long-term loans		(4,668	)		(5,746	)		(11,776	)		(12,736	)		(4,859	)		(12,258	)
Repayment of Debentures		-			-			(35,845	)		(17,763	)		-			(37,313	)
Proceeds from issuance of Debentures, net		15,118			-			73,943			55,808			15,737			76,972
Net cash provided by (used in) financing activities		7,793			4,161			42,962			54,433			8,112			44,723

Effect of exchange rate fluctuations on cash and cash equivalents		3,330			1,723			3,092			(2,387	)		3,467			3,215
Increase (decrease) in cash and cash equivalents		(7,322	)		(10,544	)		(10,421	)		5,097			(7,622	)		(10,848	)
Cash and cash equivalents at the beginning of the period		48,456			62,099			51,127			46,458			50,441			53,221
Cash from (used in) disposal groups classified as held-for-sale		-			(428	)		428			(428	)		-			446
Cash and cash equivalents at the end of the period		41,134			51,127			41,134			51,127			42,819			42,819

Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US$ 1.041)

Ellomay Capital Ltd. and its Subsidiaries

Operating Segments (Unaudited)

	Italy			Spain									USA		Netherlands			Israel
	Solar			Subsidized Solar Plants			28 MW Solar			Talasol Solar			Solar		Biogas			Dorad			Manara Pumped Stora ge		Solar*			Total reportable segments			Reconciliations			Total consolidated
	For the year ended December 31, 2024
	€ in thousands

Revenues		2,293			2,974			1,741			18,365			-		15,094			67,084			-		278			107,829			(67,362	)		40,467
Operating expenses		(109	)		(519	)		(593	)		(4,695	)		-		(13,887	)		(50,065	)		-		(142	)		(70,010	)		50,207			(19,803	)
Depreciation and amortization expenses		(89	)		(919	)		(1,088	)		(11,453	)		-		(2,897	)		(2,489	)		-		(48	)		(18,983	)		2,515			(16,468	)
Gross profit (loss)		2,095			1,536			60			2,217			-		(1,690	)		14,530			-		88			18,836			(14,640	)		4,196

Adjusted gross profit (loss)		2,095			1,536			60			2,217			-		(1,690	)		14,530			-		317²			19,065			(14,869	)		4,196
Project development costs																																	(4,101	)
General and administrative expenses																																	(6,063	)
Share of income of equity accounted investee																																	11,062
Other income, net																																	3,409
Operating profit																																	8,503
Financing income																																	2,495
Financing income in connection with derivatives and warrants, net																																	1,140
Financing expenses in connection with projects finance																																	(6,190	)
Financing expenses in connection with debentures																																	(6,641	)
Interest expenses on minority shareholder loan																																	(2,144	)
Other financing expenses																																	(8,311	)
Financing expenses, net																																	(19,651	)
Profit before taxes on income																																	(11,148	)

Segment assets as at December 31, 2024		67,546			12,633			19,403			225,452			55,564		31,779			109,579			186,333		-			708,289			(31,613	)		676,676

The results of the Talmei Yosef solar plant are presented as a discontinued operation.

The gross profit of the Talmei Yosef solar plant located in Israel is adjusted to include income from the sale of electricity (approximately €1,264 thousand) and depreciation expenses (approximately €757 thousand) under the fixed asset model, which were not recognized as revenues and depreciation expenses, respectively, under the financial asset model as per IFRIC 12.

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA (Unaudited)

	For the three months ended December 31,						For the year ended December 31,						For the three months ended December 31,			For the year ended December 31,
	2024			2023			2024			2023			2024			2024
	€ in thousands												Convenience Translation into US$ in thousands*
Net profit (loss) for the period		(11,983	)		(9,815	)		(9,464	)		625			(12,476	)		(9,851	)
Financing expenses, net		16,887			3,832			19,651			3,557			17,579			20,456
Tax benefit		(1,475	)		(799	)		(1,547	)		(1,436	)		(1,535	)		(1,610	)
Depreciation and amortization		4,126			4,265			16,468			16,012			4,295			17,143
EBITDA		7,555			(2,517	)		25,108			18,758			7,863			26,138

Convenience translation into US$ (exchange rate as at December 31, 2024: euro 1 = US$ 1.041)

Ellomay Capital Ltd.

Information for the Company’s Debenture Holders

Financial Covenants

Pursuant to the Deeds of Trust governing the Company’s Series C, Series D, Series E, Series F and Series G Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 18, 2024, and below.

Net Financial Debt

As of December 31, 2024, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €159.4 million (consisting of approximately €308.5³ million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €200.5⁴ million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), the Series D Convertible Debentures issuance (in February 2021), the Series E Secured Debentures issuance (in February 2023) and the Series F Debentures issuance (in January, April, August and November 2024)), net of approximately €41.1 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €308.5⁵ million of project finance and related hedging transactions of the Company’s subsidiaries). The Net Financial Debt and other information included in this disclosure do not include the issuance of the Company’s Series G Debentures in February 2025.

Discussion concerning Warning Signs

Upon the issuance of the Company’s Debentures, the Company undertook to comply with the “hybrid model disclosure requirements” as determined by the Israeli Securities Authority and as described in the Israeli prospectuses published in connection with the public offering of the company’s Debentures. This model provides that in the event certain financial “warning signs” exist in the Company’s consolidated financial results or statements, and for as long as they exist, the Company will be subject to certain disclosure obligations towards the holders of the Company’s Debentures.

One possible “warning sign” is the existence of a working capital deficiency if the Company’s Board of Directors does not determine that the working capital deficiency is not an indication of a liquidity problem. In examining the existence of warning signs as of December 31, 2024, the Company’s Board of Directors noted the working capital deficiency as of December 31, 2024, in the amount of approximately €23 million. The Company’s Board of Directors reviewed the Company’s financial position, outstanding debt obligations and the Company’s existing and anticipated cash resources and uses and determined that the existence of a working capital deficiency as of December 31, 2024, does not indicate a liquidity problem. In making such determination, the Company’s Board of Directors noted the following: (i) the issuance of the Company’s Series G Debentures in consideration for approximately NIS 211.7 million (net of offering expenses), which was completed after December 31, 2024 and therefore not reflected on the Company’s balance sheet, (ii) the execution of the agreement to sell tax credits in connection with the US solar projects, which is expected to contribute approximately $19 million during the next twelve months, and (iii) the Company’s positive cash flow from operating activities during 2023 and 2024.

The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.7 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.

⁴

The amount of the debentures provided above includes an amount of approximately €6.9 million associated costs, which was capitalized and discount or premium and therefore offset from the debentures amount that is recorded in the Company’s balance sheet. This amount also includes the accrued interest as at December 31, 2024 in the amount of approximately €2.1 million.

⁵

The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).

Ellomay Capital Ltd.

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series C Debenture Holders

The Deed of Trust governing the Company’s Series C Debentures (as amended on June 6, 2022, the “Series C Deed of Trust”), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of December 31, 2024, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series C Deed of Trust) was approximately €118.8 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 57.3%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA,⁶ was 6.1.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended December 31, 2024:

	For the four-quarter period ended December 31, 2024
	Unaudited
	€ in thousands
Loss for the period		(9,464	)
Financing expenses, net		19,651
Taxes on income		(1,547	)
Depreciation and amortization expenses		16,468
Share-based payments		112
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model		981
Adjusted EBITDA as defined the Series C Deed of Trust		26,201

⁶

The term “Adjusted EBITDA” is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef solar plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

Ellomay Capital Ltd.

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of December 31, 2024, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €118.8 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 57.3%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA⁷ was 6.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended December 31, 2024:

For the
four-quarter period ended
December 31,
2024

Unaudited

€ in thousands

Loss for the period (9,464 )

Financing expenses, net 19,651

Taxes on income (1,547 )

Depreciation and amortization expenses 16,468

Share-based payments 112

Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model 981

Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters⁸ 440

Adjusted EBITDA as defined the Series D Deed of Trust 26,641

⁷

The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

⁸

The adjustment is based on the results of solar plants in Italy that were connected to the grid and commenced delivery of electricity to the grid during the year ended December 31, 2024. The Company recorded revenues and only direct expenses in connection with these solar plants from the connection to the grid and until PAC (Preliminary Acceptance Certificate – reached during the fourth quarter of 2024). However, for the sake of caution, the Company included the expected fixed expenses in connection with these solar plants in the calculation of the adjustment.

Ellomay Capital Ltd.

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series E Debenture Holders

The Deed of Trust governing the Company’s Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of December 31, 2024, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series E Deed of Trust) was approximately €118.8 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 57.3%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA⁹ was 6.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended December 31, 2024:

	For the four-quarter period ended December 31, 2024
	Unaudited
	€ in thousands
Loss for the period		(9,464	)
Financing expenses, net		19,651
Taxes on income		(1,547	)
Depreciation and amortization expenses		16,468
Share-based payments		112
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model		981
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters¹⁰		440
Adjusted EBITDA as defined the Series E Deed of Trust		26,641

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. (“Ellomay Luzon Energy”)), which were pledged to the holders of the Company’s Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of December 31, 2024, the value of the assets pledged to the holders of the Series E Debentures in the Company’s books (unaudited) is approximately €41.3 million (approximately NIS 156.8 million based on the exchange rate as of such date).

⁹

The term “Adjusted EBITDA” is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

¹⁰

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series F Debenture Holders

The Deed of Trust governing the Company’s Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of December 31, 2024, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series F Deed of Trust) was approximately €118.4 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 57.4%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA¹¹ was 6.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended December 31, 2024:

For the
four-quarter period ended
December 31,
2024

Unaudited

€ in thousands

Loss for the period (9,464 )

Financing expenses, net 19,651

Taxes on income (1,547 )

Depreciation and amortization expenses 16,468

Share-based payments 112

Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model 981

Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters¹² 440

Adjusted EBITDA as defined the Series F Deed of Trust 26,641

¹¹

The term “Adjusted EBITDA” is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

¹²

Ellomay Capital Ltd. and its Subsidiaries

Information for the Company’s Debenture Holders (cont’d)

Information for the Company’s Series G Debenture Holders

The Deed of Trust governing the Company’s Series G Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series G Deed of Trust is a cause for immediate repayment. As of December 31, 2024, the Company was in compliance with the financial covenants set forth in the Series G Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series G Deed of Trust) was approximately €118.4 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 57.4%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA¹³ was 6.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series G Deed of Trust) for the four-quarter period ended December 31, 2024:

For the
four-quarter period ended
December 31,
2024

Unaudited

€ in thousands

Loss for the period (9,464 )

Financing expenses, net 19,651

Taxes on income (1,547 )

Depreciation and amortization expenses 16,468

Share-based payments 112

Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model 981

Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters¹⁴ 440

Adjusted EBITDA as defined the Series G Deed of Trust 26,641

¹³

The term “Adjusted EBITDA” is defined in the Series G Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series G Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series G Deed of Trust). The Series G Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series G Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”

¹⁴